Motley Fool Touts Poet's AI Optics Potential; DeepValue Report Maintains Wait Rating

What happened

A Motley Fool article highlights Poet Technologies' optical interposer technology as a potential beneficiary of AI data center growth, but the DeepValue Master Report cautions that the stock's $1.78B market capitalization prices rapid commercialization that has yet to materialize into repeat orders. The report emphasizes that customers can cancel purchase orders without penalty, and the Lumilens $50M PO still depends on successful qualification and volume manufacturing. With FY2025 revenue of just $1.1M against a $63M net loss, the next 6-12 months are critical for evidence of conversion, such as cumulative payments from Lumilens and Malaysia production throughput. The report assigns a WAIT rating with a base case of $16, bear case of $9, and an attractive entry at $11, while trimming above $18. Without new material data, the article does not alter the thesis; the stock remains a high-risk bet on execution milestones.

Implication

Investors should hold current positions but avoid adding until by Q4 2026 there is disclosed Lumilens engineering sample delivery and qualification language, or until contract liability increases. The stock's risk/reward is balanced with a base case of $16 and bear case of $9. Positive catalysts include Malaysia ramp and LITEON prototypes, but downside from cancellation risk remains. Position sizing must reflect the pre-revenue stage and reliance on a few customers.

Thesis delta

No shift from WAIT rating; the article provides no new material data. The key thesis remains that conversion of partnership headlines into repeat purchase orders must be proven in the next 6-12 months.